Birx Deborah 4
4 · Armata Pharmaceuticals, Inc. · Filed Mar 18, 2024
Insider Transaction Report
Form 4
Birx Deborah
DirectorChief Executive Officer
Transactions
- Award
Stock Options (Right to Buy)
2024-03-14+240,000→ 240,000 totalExercise: $3.38Exp: 2034-03-14→ Common Stock (240,000 underlying) - Award
Common Stock
2024-03-14+60,000→ 260,000 total
Footnotes (1)
- [F1]Twenty-five percent (25%) of the Stock Options shall vest on March 14th of each of 2025, 2026, 2027, and 2028.